X4 Pharmaceuticals, Inc.XFORNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P0
Near historical low
vs 5Y Ago
-0.3x
Contraction
Streak
5 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | -10.93% |
| 2024 | 13.37% |
| 2023 | 17.95% |
| 2022 | 20.56% |
| 2021 | 20.78% |
| 2020 | 39.02% |
| 2019 | -2.63% |
| 2018 | 10.14% |
| 2017 | 57.75% |
| 2016 | 40.34% |